Alessandro Noseda - 17 May 2022 Form 4 Insider Report for REGENERX BIOPHARMACEUTICALS INC (RGRX)

Role
Director
Signature
/s/ Andrew Nick as attorney-in-fact for Alessandro Noseda pursuant to a power of attorney previously filed.
Issuer symbol
RGRX
Transactions as of
17 May 2022
Net transactions value
$0
Form type
4
Filing time
19 May 2022, 17:09:22 UTC
Previous filing
04 Aug 2021
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGRX Stock Option (Right to Buy) Award $0 +240,000 $0.000000 240,000 17 May 2022 Common Stock 240,000 $0.1900 Direct F4
holding RGRX Stock Option (right to buy) 200,000 17 May 2022 Common Stock 200,000 $0.2100 Direct F1
holding RGRX Stock Option (right to buy) 200,000 17 May 2022 Common Stock 200,000 $0.3000 Direct F2
holding RGRX Stock Option (right to buy) 240,000 17 May 2022 Common Stock 240,000 $0.2800 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 100% vested.
F2 50,000 shares vest on each of 6/10/20, 6/10/21, 6/10/22 and 6/10/23.
F3 60,000 shares vest on each of 8/2/21, 8/2/22, 8/2/23 and 8/2/24.
F4 120,000 shares vest on each of 5/17/22 and 5/17/23.